• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西首都城市在 COVID-19 大流行期间心血管病死亡人数过多。

Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities.

机构信息

Serviço de Cardiologia e Cirurgia Cardiovascular, Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Departamento de Clínica Médica, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

出版信息

Heart. 2020 Dec;106(24):1898-1905. doi: 10.1136/heartjnl-2020-317663. Epub 2020 Oct 15.

DOI:10.1136/heartjnl-2020-317663
PMID:33060261
Abstract

INTRODUCTION

During the COVID-19 pandemic, excess mortality has been reported, while hospitalisations for acute cardiovascular events reduced. Brazil is the second country with more deaths due to COVID-19. We aimed to evaluate excess cardiovascular mortality during COVID-19 pandemic in 6 Brazilian capital cities.

METHODS

Using the Civil Registry public database, we evaluated total and cardiovascular excess deaths, further stratified in specified cardiovascular deaths (acute coronary syndromes and stroke) and unspecified cardiovascular deaths in the 6 Brazilian cities with greater number of COVID-19 deaths (São Paulo, Rio de Janeiro, Fortaleza, Recife, Belém, Manaus). We compared observed with expected deaths from epidemiological weeks 12-22 of 2020. We also compared the number of hospital and home deaths during the period.

RESULTS

There were 65 449 deaths and 17 877 COVID-19 deaths in the studied period and cities for 2020. Cardiovascular mortality increased in most cities, with greater magnitude in the Northern capitals. However, while there was a reduction in specified cardiovascular deaths in the most cities, the Northern capitals showed an increase of these events. For unspecified cardiovascular deaths, there was a marked increase in all cities, which strongly correlated to the rise in home deaths (r=0.86, p=0.01).

CONCLUSION

Excess cardiovascular mortality was greater in the less developed cities, possibly associated with healthcare collapse. Specified cardiovascular deaths decreased in the most developed cities, in parallel with an increase in unspecified cardiovascular and home deaths, presumably as a result of misdiagnosis. Conversely, specified cardiovascular deaths increased in cities with a healthcare collapse.

摘要

简介

在 COVID-19 大流行期间,已报告超额死亡率,而急性心血管事件的住院率下降。巴西是 COVID-19 死亡人数第二多的国家。我们旨在评估 COVID-19 大流行期间巴西 6 个首府城市的心血管超额死亡率。

方法

我们使用民事登记公共数据库,评估了 6 个拥有更多 COVID-19 死亡人数的巴西城市(圣保罗、里约热内卢、福塔雷萨、累西腓、贝伦、马瑙斯)的总心血管超额死亡和心血管特定死亡(急性冠状动脉综合征和中风)和非特定心血管死亡。我们将观察到的死亡人数与 2020 年第 12-22 周的预期死亡人数进行比较。我们还比较了该期间的医院和家庭死亡人数。

结果

在所研究的期间和城市中,2020 年有 65449 人死亡和 17877 人死于 COVID-19。大多数城市的心血管死亡率增加,北部首府的增幅更大。然而,虽然大多数城市的特定心血管死亡人数有所减少,但北部首府的这些事件有所增加。对于非特定心血管死亡,所有城市都有明显增加,这与家庭死亡人数的增加密切相关(r=0.86,p=0.01)。

结论

欠发达城市的心血管超额死亡率更高,可能与医疗保健系统崩溃有关。最发达城市的特定心血管死亡人数下降,同时非特定心血管和家庭死亡人数增加,可能是误诊的结果。相反,医疗保健系统崩溃的城市的特定心血管死亡人数增加。

相似文献

1
Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities.巴西首都城市在 COVID-19 大流行期间心血管病死亡人数过多。
Heart. 2020 Dec;106(24):1898-1905. doi: 10.1136/heartjnl-2020-317663. Epub 2020 Oct 15.
2
[Excess deaths during the COVID-19 pandemic: underreporting and regional inequalities in Brazil].[新冠疫情期间巴西的超额死亡:漏报情况及地区不平等现象]
Cad Saude Publica. 2021 Feb 5;37(1):e00259120. doi: 10.1590/0102-311X00259120. eCollection 2021.
3
Multicity study of air pollution and mortality in Latin America (the ESCALA study).拉丁美洲空气污染与死亡率的多城市研究(ESCALA研究)。
Res Rep Health Eff Inst. 2012 Oct(171):5-86.
4
[Excess deaths from respiratory causes in eight Brazilian metropolises during the first six months of the COVID-19 pandemic].[新冠疫情大流行前六个月巴西八个大都市因呼吸道疾病导致的超额死亡情况]
Cad Saude Publica. 2021 May 17;37(5):e00328720. doi: 10.1590/0102-311X00328720. eCollection 2021.
5
High discrepancies in the mortality of hospitalized patients with COVID-19 in the two most economically important states in Brazil.巴西两个经济最重要的州住院 COVID-19 患者死亡率差异巨大。
Rev Bras Epidemiol. 2021 Dec 1;24:e210056. doi: 10.1590/1980-549720210056. eCollection 2021 Sep 1.
6
Patterns of hospital utilization in the Unified Health System in six Brazilian capitals: comparison between the year before and the first six first months of the COVID-19 pandemic.巴西六个首府的统一卫生系统中的医院利用模式:与 COVID-19 大流行前一年和前六个月的比较。
BMC Health Serv Res. 2021 Sep 17;21(1):976. doi: 10.1186/s12913-021-07006-x.
7
In-Hospital Mortality from Cardiovascular Diseases in Brazil during the First Year of The COVID-19 Pandemic.巴西在 COVID-19 大流行第一年的心血管疾病院内死亡率。
Arq Bras Cardiol. 2022 Jul;119(1):37-45. doi: 10.36660/abc.20210468.
8
[Age-adjusted COVID-19 mortality in state capitals in different regions of Brazil].[巴西不同地区首府的年龄调整后新冠病毒疾病死亡率]
Cad Saude Publica. 2021 Jul 7;37(6):e00039221. doi: 10.1590/0102-311X00039221. eCollection 2021.
9
Excess mortality from all causes during the COVID-19 pandemic in the city of Rio de Janeiro, Brazil.巴西里约热内卢市在 COVID-19 大流行期间的全因超额死亡率。
Rev Bras Epidemiol. 2023 Feb 20;26:e230013. doi: 10.1590/1980-549720230013. eCollection 2023.
10
[Mortality trends due to myocardial ischemia in capital cities of the metropolitan areas of Brazil, 1979-89].[1979 - 1989年巴西大都市区首府城市心肌缺血所致死亡率趋势]
Arq Bras Cardiol. 1995 Mar;64(3):213-6.

引用本文的文献

1
Analysis of mortality by cardiovascular disease subgroups in Brazil before and during the COVID-19 pandemic (2000-2022) by sex and age group.按性别和年龄组分析巴西在2019冠状病毒病大流行之前和期间(2000 - 2022年)心血管疾病亚组的死亡率。
Rev Bras Epidemiol. 2025 Jun 27;28:e250033. doi: 10.1590/1980-549720250033. eCollection 2025.
2
Difference in clinical courses and causes of COVID-19-related deaths in hospitalized patients infected with omicron and delta variants: A retrospective study in Japan.感染奥密克戎和德尔塔变异株的住院患者中与 COVID-19 相关死亡的临床病程和原因差异:日本的一项回顾性研究。
GHM Open. 2024 Jul 31;4(1):23-31. doi: 10.35772/ghmo.2023.01025.
3
The side effects of the pandemic on all-cause postoperative mortality in a COVID reference Hospital in Brazil: a before and after cohort study with 15156 patients.
疫情对巴西一家新冠定点医院全因术后死亡率的影响:一项针对15156名患者的前后队列研究。
Braz J Anesthesiol. 2025 Mar-Apr;75(2):844600. doi: 10.1016/j.bjane.2025.844600. Epub 2025 Feb 22.
4
[Overall excess mortality and COVID-19 mortality in Brazil and Brazilian regions in 2020].[2020年巴西及巴西各地区的总体超额死亡率和新冠病毒病死亡率]
Cad Saude Publica. 2025 Jan 13;40(11):e00217323. doi: 10.1590/0102-311XPT217323. eCollection 2025.
5
Excess cardiovascular mortality across multiple COVID-19 waves in the United States from March 2020 to March 2022.2020 年 3 月至 2022 年 3 月美国多波次 COVID-19 疫情期间心血管病超额死亡。
Nat Cardiovasc Res. 2023 Mar;2(3):322-333. doi: 10.1038/s44161-023-00220-2. Epub 2023 Feb 27.
6
Cardiovascular Statistics - Brazil 2023.心血管统计数据 - 巴西2023年
Arq Bras Cardiol. 2024 Feb;121(2):e20240079. doi: 10.36660/abc.20240079.
7
Cause-Specific Excess Mortality During the COVID-19 Pandemic (2020-2021) in 12 Countries of the C-MOR Consortium.C-MOR联盟12个国家在2019冠状病毒病大流行期间(2020 - 2021年)特定病因超额死亡率
J Epidemiol Glob Health. 2024 Jun;14(2):337-348. doi: 10.1007/s44197-024-00242-4. Epub 2024 May 22.
8
Persistent high mortality rates for Diabetes Mellitus and Hypertension after excluding deaths associated with COVID-19 in Brazil, 2020-2022.2020 - 2022年巴西在排除与新冠病毒病相关的死亡病例后,糖尿病和高血压的持续高死亡率。
PLOS Glob Public Health. 2024 May 9;4(5):e0002576. doi: 10.1371/journal.pgph.0002576. eCollection 2024.
9
A comprehensive analysis of cardiovascular mortality trends in Peru from 2017 to 2022: Insights from 183,386 deaths of the national death registry.2017年至2022年秘鲁心血管疾病死亡率趋势的综合分析:来自国家死亡登记处183,386例死亡数据的见解
Am Heart J Plus. 2023 Oct 20;35:100335. doi: 10.1016/j.ahjo.2023.100335. eCollection 2023 Nov.
10
What can multiple causes of death tell about cardiovascular mortality during COVID-19 pandemic in the United States?在 COVID-19 大流行期间,美国有多少种死因与心血管疾病死亡有关?
J Public Health (Oxf). 2024 Feb 23;46(1):97-106. doi: 10.1093/pubmed/fdad278.